REGULATING A REVOLUTION.

The article explores efforts to regulate gene therapies by health authorities. Several of these health authorities are discussed including the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). Additional topics discussed include the small number of deaths attributed to gene therapy, the first trials of gene editing inside the body, and how the EMA and FDA both use data-driven approaches to assessing drug safety and advocacy.